SAM
CYTK icon

Sherman Asset Management’s Cytokinetics CYTK Stock Holding History

Sherman Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Hold
142
– – 0.01% 117
2026
Q1 		$9.36K Hold
142
– – 0.01% 130
2025
Q4 		$9.02K Hold
142
– – 0.01% 133
2025
Q3 		$7.8K Hold
142
– – 0.01% 133
2025
Q2 		$4.69K Hold
142
– – ﹤0.01% 139
2025
Q1 		$5.71K Hold
142
– – 0.01% 139
2024
Q4 		$6.68K Buy
+142
New +$7.38K 0.01% 137

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sherman Asset Management's CYTK Position: Q2 2026 in Review

Sherman Asset Management held its Cytokinetics (CYTK) position steady in Q2 2026 at 142 shares worth $12.1K. The position accounts for 0.01% of the portfolio, ranked #117.

Sherman Asset Management first reported a position in CYTK in Q4 2024 and has held it in 7 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Sherman Asset Management held 142 shares of Cytokinetics worth $12.1K as of Q2 2026.
  • Sherman Asset Management left its Cytokinetics share count unchanged in Q2 2026.
  • Cytokinetics made up 0.01% of Sherman Asset Management's portfolio in Q2 2026, its #117 holding.
  • Sherman Asset Management first reported a position in Cytokinetics in Q4 2024 and has held it in 7 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Sherman Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.